Impact of chronotype and time perspective on the processing of scripts.

Int J Psychophysiol

Department of Psychology, Humboldt University Berlin, Germany; Berlin School of Mind and Brain, Germany.

Published: May 2014

Little is known about the impact of temporal orientation (chronotype; time perspective) on cognitive performance. This study adopted a psychophysiological approach to explore how chronotype (morningness-eveningness) and time perspective (present; future) influence time succession as another aspect of psychological time that is entailed within script knowledge. In a temporal judgment task, participants decided which of the two presented sub-events (e.g., get new batteries-set right time on alarm clock) comes earlier (or later) within a given script (e.g., changing batteries in an alarm clock). Behavioral and pupillary data suggest a differential impact of chronotype and time perspective on script knowledge and cognitive performance. The impact of time perspective on the processing of temporal information entailed in script knowledge appears linked to match or mismatch conditions between a strong focus on future outcomes associated with future time perspective and the task of identifying either the later (future-oriented) or the earlier (past-oriented) sub-event. Concerning the chronotype, evening types process items in which chronological time succession is violated (i.e., reversely presented items) more accurately than morning types. Indexed by pupillary data, the impact of chronotype may relate to more general cognitive abilities. The psychophysiological data derived in this study suggests that evening types typically outperform morning types in various measures such working memory capacity and verbal intelligence simply because they invest more cognitive resources than morning types.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpsycho.2014.02.004DOI Listing

Publication Analysis

Top Keywords

time perspective
24
impact chronotype
12
chronotype time
12
script knowledge
12
morning types
12
time
10
perspective processing
8
cognitive performance
8
time succession
8
entailed script
8

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.

Background: In preparation for therapeutic trails involving patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), there is a need for valid, disease-specific caregiver-reported outcome (CRO) measures capable of tracking symptomatic burden in response to therapy over time. CROs are useful tools in clinical trials for individuals with AD, MCI, and dementia who are unable to self-report. In addition, CROs are accepted by the United States Food and Drug Administration to support regulatory claims.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China.

Background: Effective early intervention of mild cognitive impairment (MCI) is the key for preventing dementia. However, there is currently no drug for MCI. As a multi-targeted neuroprotective agent, butylphthalide has been demonstrated to repair cognition in patients with vascular cognitive impairment, and has the potential to treat MCI due to Alzheimer's disease (AD).

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Eli Lilly and Company, Indianapolis, IN, USA.

Background: The advent of disease-modifying therapies in Alzheimer's disease (AD) necessitates a nuanced understanding of how therapies impact disease processes. Over the past decades, AD clinical trials have primarily relied on classical statistical analysis methodology such as the mixed model for repeated measures (MMRM) to estimate treatment effects. These conventional treatment effect quantifications are given as group differences in clinical outcome measures at a single visit.

View Article and Find Full Text PDF

Background: Understanding the fundamental differences between the human and pre-human brain is a prerequisite for designing meaningful models and therapies for AD. Expressed CHRFAM7A, a human restricted gene with carrier frequency of 75% in the human population predicts profound translational significance.

Method: The physiological role of CHRFAM7A in human brain is explored using multiomics approach on 600 post mortem human brain tissue samples (ROSMAP).

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Background: Hearing rehabilitation has been a promising approach to improve cognitive outcomes. An ongoing study identified some barriers to engage patients in counseling sessions and using their hearing devices. Here we present the results from the first stage of a Sense-Cog Brazil pilot study, the recruitment phase.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!